RERE expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.963300E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.275500E-02
Normal-vs-Stage2
7.841600E-03
Normal-vs-Stage3
9.696600E-03
Normal-vs-Stage4
6.623200E-01
Stage1-vs-Stage2
6.413200E-01
Stage1-vs-Stage3
2.707900E-02
Stage1-vs-Stage4
1.212010E-01
Stage2-vs-Stage3
6.400200E-02
Stage2-vs-Stage4
2.138300E-02
Stage3-vs-Stage4
1.402050E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.822100E-03
Normal-vs-AfricanAmerican
1.044190E-01
Normal-vs-Asian
2.736800E-01
Caucasian-vs-AfricanAmerican
4.583000E-01
Caucasian-vs-Asian
3.774000E-01
AfricanAmerican-vs-Asian
8.304200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.503200E-03
Normal-vs-Female
1.980290E-02
Male-vs-Female
3.915400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.019800E-01
Normal-vs-Age(41-60Yrs)
2.286100E-02
Normal-vs-Age(61-80Yrs)
7.996300E-03
Normal-vs-Age(81-100Yrs)
1.675590E-03
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.845000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.839000E-04
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.733900E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.131600E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.900420E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.990200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.351910E-02
Normal-vs-Daily Drinker
4.615100E-03
Normal-vs-Weekly Drinker
3.461700E-02
Normal-vs-Occasional Drinker
1.614840E-01
Normal-vs-Social Drinker
3.825800E-02
Non Drinker-vs-Daily Drinker
8.842200E-01
Non Drinker-vs-Weekly Drinker
4.830800E-01
Non Drinker-vs-Occasional Drinker
6.976200E-02
Non Drinker-vs-Social Drinker
4.976000E-01
Daily Drinker-vs-Weekly Drinker
5.196400E-01
Daily Drinker-vs-Occasional Drinker
7.871700E-02
Daily Drinker-vs-Social Drinker
5.431800E-01
Weekly Drinker-vs-Occasional Drinker
3.389400E-01
Weekly Drinker-vs-Social Drinker
9.783400E-01
Occasional Drinker-vs-Social Drinker
3.237000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.493400E-01
Normal-vs-Grade 2
1.169050E-01
Normal-vs-Grade 3
6.153800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.206200E-01
Grade 1-vs-Grade 3
5.790000E-01
Grade 1-vs-Grade 4
3.493400E-01
Grade 2-vs-Grade 3
4.364800E-01
Grade 2-vs-Grade 4
1.169050E-01
Grade 3-vs-Grade 4
6.153800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.560220E-02
Normal-vs-NonDiabetic
7.378900E-03
Diabetic-vs-NonDiabetic
6.775400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.474100E-02
Normal-vs-NoPancreatitis
7.724100E-03
Pancreatitis-vs-NoPancreatitis
6.850600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.937700E-03
Normal-vs-N1
7.921800E-03
N0-vs-N1
6.679000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.803700E-02
Normal-vs-TP53-NonMutant
3.360400E-02
TP53-Mutant-vs-TP53-NonMutant
4.091200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
